Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

ResearcherID: H-9028-2013
Loop profile: 600862
SciProfiles: 289464

Activities

Collapse all

Employment (1)

CHU Caen Normandy: Caen, FR

2007 to present | pharmacovigilant (clinical research)
Employment
Source: Self-asserted source
peyro-saint-paul

Works (27)

Pharmacokinetics and safety of daptomycin administered subcutaneously in healthy volunteers: a single-blinded randomized crossover trial

Journal of Antimicrobial Chemotherapy
2024-11-04 | Journal article
DOI: 10.1093/jac/dkae324
Contributors: Charles Maurille; Aurélie Baldolli; Christian Creveuil; Jean-Jacques Parienti; Jocelyn Michon; Laure Peyro-Saint-Paul; Sylvie Brucato; Sylvie Dargere; Emmanuelle Comets; Marie-Clémence Verdier et al.
Source: check_circle
Crossref

Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non-valvular atrial fibrillation: protocol for a prospective, randomised, open-label, blinded endpoint trial (APIDP2)

BMJ Open
2024-09 | Journal article
DOI: 10.1136/bmjopen-2024-089353
Contributors: Maxence Ficheux; Laure Peyro-Saint-Paul; Dorothée Balayn; Blandine Lecrux; Manon Brossier; Antoine Morin; Antoine Lanot; Chloé Peron; Marion Boulanger; Marie Brionne et al.
Source: check_circle
Crossref

Compensating patients in trials: Perspectives from an ethical committee versus sponsor

European Journal of Clinical Investigation
2023-10 | Journal article
DOI: 10.1111/eci.14044
Contributors: Laure Peyro‐Saint‐Paul; Cathy Gaillard; Adeline Paris; Charlotte Gourio; Céleste Zerger; Maxence Ficheux; Guillaume Grandazzi; Jean‐Jacques Parienti; Rémy Morello
Source: check_circle
Crossref

Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics

Nephrology Dialysis Transplantation
2023-07-31 | Journal article
DOI: 10.1093/ndt/gfad087
Contributors: Laure Peyro-Saint-Paul; Clémence Bechade; Alexandre Cesbron; Danièle Debruyne; Marie Brionne; Sylvie Brucato; Mélanie Hanoy; Audrey Dumont; Anais R Briant; Jean-Jacques Parienti et al.
Source: check_circle
Crossref

Bioavailability of dissolved and crushed single tablets of bictegravir, emtricitabine, tenofovir alafenamide in healthy adults: the SOLUBIC randomized crossover study

Journal of Antimicrobial Chemotherapy
2023-01-05 | Journal article
DOI: 10.1093/jac/dkac369
Contributors: Laurent Hocqueloux; Sandrine Lefeuvre; Julie Bois; Sylvie Brucato; Antoine Alix; Cécile Valentin; Laure Peyro-Saint-Paul; Laurence Got; François Fournel; Sylvie Dargere et al.
Source: check_circle
Crossref

Drug safety in multiple sclerosis: From reporting to signal detection and benefit-risk management

Revue Neurologique
2021-05 | Journal article
DOI: 10.1016/j.neurol.2021.01.009
Contributors: L. Peyro-Saint-Paul; S. Fedrizzi; G. Defer
Source: check_circle
Crossref

Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial

Drug Safety
2021-02-13 | Journal article
DOI: 10.1007/s40264-020-01009-z
Contributors: Gilles Defer; Sophie Fedrizzi; Damien Chevanne; François Montastruc; Anais R. Briant; Jean-Jacques Parienti; Laure Peyro-Saint-Paul; G. Defer; N. Derache; P. Branger et al.
Source: check_circle
Crossref

Cushing’s syndrome due to interaction between ritonavir or cobicistat and corticosteroids: a case–control study in the French Pharmacovigilance Database

Journal of Antimicrobial Chemotherapy
2019-11-01 | Journal article
DOI: 10.1093/jac/dkz324
Contributors: Laure Peyro-Saint-Paul; Paul Besnier; Ludivine Demessine; Michel Biour; Dominique Hillaire-Buys; Claire de Canecaude; Sophie Fedrizzi; Jean-Jacques Parienti
Source: check_circle
Crossref

Severe bone pain with teriflunomide: Five case reports and review of the French pharmacovigilance database

Therapies
2019-07 | Journal article
DOI: 10.1016/j.therap.2019.07.006
Part of ISSN: 0040-5957
Source: Self-asserted source
peyro-saint-paul

Risk and Cost Associated With Drug–Drug Interactions Among Aging HIV Patients Receiving Combined Antiretroviral Therapy in France

Open Forum Infectious Diseases
2019-03-01 | Journal article
DOI: 10.1093/ofid/ofz051
Part of ISSN: 2328-8957
Source: Self-asserted source
peyro-saint-paul

FIVHeMA: Intraventricular fibrinolysis versus external ventricular drainage alone in aneurysmal subarachnoid hemorrhage: A randomized controlled trial

Neurochirurgie
2019-02 | Journal article
DOI: 10.1016/j.neuchi.2018.11.004
Part of ISSN: 0028-3770
Source: Self-asserted source
peyro-saint-paul

Dedicated mobile application for drug adverse reaction reporting by patients with relapsing remitting multiple sclerosis (Vigip-SEP study): study protocol for a randomized controlled trial

Trials
2018-12 | Journal article
DOI: 10.1186/s13063-018-2560-4
Part of ISSN: 1745-6215
Source: Self-asserted source
peyro-saint-paul

Pharmacokinetics of 300 mg/d Intraperitoneal Daptomycin: New Insight from the DaptoDP Study.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis
2018-11 | Journal article
DOI: 10.3747/pdi.2017.00256
PMID: 30413641
Contributors: Saint Paul LP; Ficheux M; Debruyne D; Loilier M; Bouvier N; Morello R; Verdon R; Le Blanc E; Cattoir V; Lobbedez T
Source: Self-asserted source
peyro-saint-paul via Europe PubMed Central

Real versus sham proximal biofield therapy in the treatment of warts of the hands and feet in adults: study protocol for a randomized controlled trial (MAGNETIK study)

Trials
2017-12 | Journal article
DOI: 10.1186/s13063-017-1994-4
Part of ISSN: 1745-6215
Source: Self-asserted source
peyro-saint-paul

Pharmacokinetics of Intraperitoneal Daptomycin in Patients with Peritoneal Dialysis-Related Peritonitis

Peritoneal Dialysis International
2017-01 | Journal article
DOI: 10.3747/pdi.2016.00028
Part of ISSN: 0896-8608
Part of ISSN: 1718-4304
Source: Self-asserted source
peyro-saint-paul

Sécurité des essais cliniques : accompagnement de l’investigateur par le vigilant pour la publication des données de sécurité. Une ligne directrice du groupe REVISE

Therapies
2016-10 | Journal article
DOI: 10.1016/j.therap.2016.05.007
Part of ISSN: 0040-5957
Source: Self-asserted source
peyro-saint-paul
grade
Preferred source (of 3)‎

Chemotherapy (platinum and pemetrexed) in combination with erlotinib in non-small cell lung cancer induces major gastrointestinal toxicity: two case reports from the FLARE/GFPC 03-2013 study

Journal of Clinical Pharmacy and Therapeutics
2016-08 | Journal article
DOI: 10.1111/jcpt.12406
Part of ISSN: 0269-4727
Source: Self-asserted source
peyro-saint-paul

Sorafenib in metastatic uveal melanoma: efficacy, toxicity and health-related quality of life in a multicentre phase II study

British Journal of Cancer
2016-06 | Journal article
DOI: 10.1038/bjc.2016.119
Part of ISSN: 0007-0920
Part of ISSN: 1532-1827
Source: Self-asserted source
peyro-saint-paul

Efficacy and safety profile of memantine in patients with cognitive impairment in multiple sclerosis: A randomized, placebo-controlled study

Journal of the Neurological Sciences
2016-04 | Journal article
DOI: 10.1016/j.jns.2016.02.012
Part of ISSN: 0022-510X
Source: Self-asserted source
peyro-saint-paul

Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

Expert Opinion on Drug Metabolism & Toxicology
2016-03-03 | Journal article
DOI: 10.1517/17425255.2016.1136288
Part of ISSN: 1742-5255
Part of ISSN: 1744-7607
Source: Self-asserted source
peyro-saint-paul

Arrêt soudain des médicaments spécifiques de la démence au stade modéré à sévère de la maladie d’Alzheimer en institution : étude pilote longitudinale descriptive

Therapies
2015-07 | Journal article
DOI: 10.2515/therapie/2014217
Part of ISSN: 0040-5957
Source: Self-asserted source
peyro-saint-paul

[New frequent adverse reaction of PPI in older adults: mild hyponatremia].

2014 | Journal article
DOI:

10.2515/therapie/2014019

PMID:

24926634
Contributors: Peyro Saint Paul L; Martin J; Buon M; Gaillard C; Fedrizzi S; Mosquet B; Coquerel A
Source: Self-asserted source
peyro-saint-paul via Europe PubMed Central

Remplacement de la fluindione par la warfarine chez le sujet âgé

La Presse Médicale
2014-02 | Journal article
DOI: 10.1016/j.lpm.2013.06.018
Part of ISSN: 0755-4982
Source: Self-asserted source
peyro-saint-paul
grade
Preferred source (of 2)‎

Risk of Proton Pump Inhibitor-Induced Mild Hyponatremia in Older Adults

Journal of the American Geriatrics Society
2013-11 | Journal article
DOI: 10.1111/jgs.12534
Part of ISSN: 0002-8614
Source: Self-asserted source
peyro-saint-paul
grade
Preferred source (of 2)‎

Moderate, Potentially Drug-Induced Hyponatremia in Older Adults: Is There a Benefit in Drug Reduction?

Journal of the American Geriatrics Society
2012-10 | Journal article
DOI: 10.1111/j.1532-5415.2012.04186.x
Part of ISSN: 0002-8614
Source: Self-asserted source
peyro-saint-paul
grade
Preferred source (of 2)‎

Daptomycin Compatibility in Peritoneal Dialysis Solutions

Peritoneal Dialysis International
2011-07 | Journal article
DOI: 10.3747/pdi.2010.00183
Part of ISSN: 0896-8608
Part of ISSN: 1718-4304
Source: Self-asserted source
peyro-saint-paul
grade
Preferred source (of 2)‎

Les colites ischémiques en psychiatrie

Gastroentérologie Clinique et Biologique
2008-06 | Journal article
DOI: 10.1016/j.gcb.2008.02.001
Part of ISSN: 0399-8320
Source: Self-asserted source
peyro-saint-paul

Peer review (1 review for 1 publication/grant)

Review activity for Journal of bioethical inquiry. (1)
How many people are using ORCID?